121 related articles for article (PubMed ID: 36049476)
1. Role of the ABO Blood Groups as a Risk Factor for Retinal Vein Occlusion.
Posch-Pertl L; List W; Michelitsch M; Pinter-Hausberger S; Posch F; Innauer F; Renner W; Weger M
Ophthalmic Res; 2023; 66(1):164-169. PubMed ID: 36049476
[TBL] [Abstract][Full Text] [Related]
2. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.
Gori AM; Marcucci R; Fatini C; Gensini F; Sticchi E; Sodi A; Cappelli S; Menchini U; Gensini GF; Abbate R; Prisco D
Thromb Haemost; 2004 Jul; 92(1):54-60. PubMed ID: 15213845
[TBL] [Abstract][Full Text] [Related]
3. Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion.
Szigeti A; Ecsedy M; Schneider M; Lénárt L; Lesch B; Nagy ZZ; Fekete A; Récsán Z
PLoS One; 2016; 11(11):e0166544. PubMed ID: 27832196
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms associated with the prevalence of retinal vein occlusion in a Greek population.
Christodoulou A; Bagli E; Gazouli M; Moschos MM; Kitsos G
Int Ophthalmol; 2019 Nov; 39(11):2637-2648. PubMed ID: 31065901
[TBL] [Abstract][Full Text] [Related]
5. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
[TBL] [Abstract][Full Text] [Related]
6. Retinal vein occlusion and the risk of stroke development: a 9-year nationwide population-based study.
Rim TH; Kim DW; Han JS; Chung EJ
Ophthalmology; 2015 Jun; 122(6):1187-94. PubMed ID: 25726093
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1 gene rs2071746 polymorphism in retinal vein occlusion.
Posch-Pertl L; List W; Michelitsch M; Pinter-Hausberger S; Berisha B; Posch F; Kloeckl L; Renner W; Weger M
Ophthalmic Genet; 2022 Oct; 43(5):627-632. PubMed ID: 35762119
[TBL] [Abstract][Full Text] [Related]
8. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
[TBL] [Abstract][Full Text] [Related]
9. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.
Russo PD; Damante G; Pasca S; Turello M; Barillari G
Clin Appl Thromb Hemost; 2015 May; 21(4):373-7. PubMed ID: 24569626
[TBL] [Abstract][Full Text] [Related]
10. Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis.
Dentali F; Di Minno MN; Turato S; Crestani S; Ambrosino P; Bonfanti C; Di Minno G; Ageno W; Franchini M
Thromb Res; 2014 Aug; 134(2):264-7. PubMed ID: 24882273
[TBL] [Abstract][Full Text] [Related]
11. Demographic characteristics, patterns and risk factors for retinal vein occlusion in Nepal: a hospital-based case-control study.
Thapa R; Paudyal G; Bernstein PS
Clin Exp Ophthalmol; 2010 Aug; 38(6):583-90. PubMed ID: 20584017
[TBL] [Abstract][Full Text] [Related]
12. Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A gene polymorphism in patients with retinal vein occlusion.
Weger M; Steinbrugger I; Renner W; Pöschl EM; Brockmann T; Rabensteiner DF; El-Shabrawi Y; Haas A
Curr Eye Res; 2013 Dec; 38(12):1278-82. PubMed ID: 23972066
[TBL] [Abstract][Full Text] [Related]
13. Thrombophilic and cardiovascular risk factors for retinal vein occlusion.
Bucciarelli P; Passamonti SM; Gianniello F; Artoni A; Martinelli I
Eur J Intern Med; 2017 Oct; 44():44-48. PubMed ID: 28684050
[TBL] [Abstract][Full Text] [Related]
14. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population.
Nakao M; Matsuo K; Hosono S; Ogata S; Ito H; Watanabe M; Mizuno N; Iida S; Sato S; Yatabe Y; Yamao K; Ueda R; Tajima K; Tanaka H
Cancer Sci; 2011 May; 102(5):1076-80. PubMed ID: 21306478
[TBL] [Abstract][Full Text] [Related]
15. Retinal vein occlusion is associated with stroke independent of underlying cardiovascular disease.
Bakhoum CY; Madala S; Long CK; Adabifirouzjaei F; Freeman WR; Goldbaum MH; DeMaria AN; Bakhoum MF
Eye (Lond); 2023 Mar; 37(4):764-767. PubMed ID: 35411111
[TBL] [Abstract][Full Text] [Related]
16. Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion.
Ortak H; Demir S; Ateş O; Söğüt E; Alim S; Benli I
Exp Eye Res; 2013 Aug; 113():151-5. PubMed ID: 23791966
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study.
Zöller B; Li X; Sundquist J; Sundquist K
J Thromb Thrombolysis; 2016 Nov; 42(4):505-12. PubMed ID: 27283943
[TBL] [Abstract][Full Text] [Related]
18. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
19. Similarities and differences in systemic risk factors for retinal artery occlusion and retinal vein occlusion: A nationwide case-control study.
Ørskov M; Vorum H; Larsen TB; Lip GYH; Bek T; Skjøth F
Int Ophthalmol; 2023 Mar; 43(3):817-824. PubMed ID: 36056288
[TBL] [Abstract][Full Text] [Related]
20. Association between retinal vein occlusion and an increased risk of acute myocardial infarction: A nationwide population-based follow-up study.
Chen YY; Sheu SJ; Hu HY; Chu D; Chou P
PLoS One; 2017; 12(9):e0184016. PubMed ID: 28898259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
